DAFNA Capital Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,314
| Closed | -$663K | – | 89 |
|
|
2019
Q3 | $663K | Buy |
+26,314
| New | +$663K | 0.25% | 66 |
|
|
2018
Q4 | – | Sell |
-10,677
| Closed | -$747K | – | 85 |
|
|
2018
Q3 | $747K | Hold |
10,677
| – | – | 0.31% | 55 |
|
|
2018
Q2 | $792K | Hold |
10,677
| – | – | 0.37% | 55 |
|
|
2018
Q1 | $1.02M | Sell |
10,677
-11,694
| -52% | -$1.11M | 0.49% | 53 |
|
|
2017
Q4 | $2.89M | Sell |
22,371
-1,381
| -6% | -$178K | 1.56% | 22 |
|
|
2017
Q3 | $1.61M | Sell |
23,752
-543
| -2% | -$36.9K | 1% | 34 |
|
|
2017
Q2 | $2.3M | Sell |
24,295
-492
| -2% | -$46.5K | 1.64% | 18 |
|
|
2017
Q1 | $3.56M | Sell |
24,787
-7,601
| -23% | -$1.09M | 3.01% | 6 |
|
|
2016
Q4 | $4.1M | Buy |
+32,388
| New | +$4.1M | 3.61% | 6 |
|
|
2016
Q3 | – | Sell |
-2,016
| Closed | -$232K | – | 95 |
|
|
2016
Q2 | $232K | Hold |
2,016
| – | – | 0.18% | 75 |
|
|
2016
Q1 | $229K | Buy |
+2,016
| New | +$229K | 0.2% | 76 |
|